APYP begin process for Acquisition of SleepX Ltd.
Post# of 107225
(Total Views: 661)
Posted On: 01/28/2021 8:45:46 AM
APYP begin process for Acquisition of SleepX Ltd.
Press Release | 01/28/2021
AppYea, Inc begins the process to acquire Sleepx Ltd. and Nexense Technologies USA Inc.
Boca Raton, FL, and Rehovot, Israel (OTC Pink: APYP) AppYea, Inc. ("AppYea" or the "Company"
begun the process to acquire 100% of the outstanding shares of SleepX Ltd., a company formed under the laws of Israel ("SleepX" and Nexense Technologies USA Inc., a Delaware corporation.
Todd Violette, CEO of AppYea stated, "I have been very impressed with the SleepX management team in Israel and SleepXs products and technology. SleepX holds a portfolio of patents and products designed to prevent snoring and sleep apnea, which I believe present a unique opportunity for AppYea."
AppYea management's review of information from Research and Markets September 18, 2020 industry report, indicates the global sleep apnea device market is forecast to increase to US$9.29 billion in 2024, growing at a compounded annual growth rate of 7.94% between 2020-2024. The same report found that the fastest-growing regional market wasNorth America, with the highest incidence of obstructive sleep apnea cases, provided that Europealso represents a large available market.
"SleepX has developed a unique technology for monitoring sleep apnea. The Technology and IP are protected via international patents - sleep apnea detection and sleep phases analysis through sound wave analysis, developed in the Biomedical Department of Ben Gurion University in Beer Sheva, Israel.Based on this technology, one of the leading products SleepX offers is a unique night bracelet for the treatment of snoring using artificial Intelligence", said Bary Molchadsky, CEO of SleepX.
Press Release | 01/28/2021
AppYea, Inc begins the process to acquire Sleepx Ltd. and Nexense Technologies USA Inc.
Boca Raton, FL, and Rehovot, Israel (OTC Pink: APYP) AppYea, Inc. ("AppYea" or the "Company"
begun the process to acquire 100% of the outstanding shares of SleepX Ltd., a company formed under the laws of Israel ("SleepX" and Nexense Technologies USA Inc., a Delaware corporation. Todd Violette, CEO of AppYea stated, "I have been very impressed with the SleepX management team in Israel and SleepXs products and technology. SleepX holds a portfolio of patents and products designed to prevent snoring and sleep apnea, which I believe present a unique opportunity for AppYea."
AppYea management's review of information from Research and Markets September 18, 2020 industry report, indicates the global sleep apnea device market is forecast to increase to US$9.29 billion in 2024, growing at a compounded annual growth rate of 7.94% between 2020-2024. The same report found that the fastest-growing regional market wasNorth America, with the highest incidence of obstructive sleep apnea cases, provided that Europealso represents a large available market.
"SleepX has developed a unique technology for monitoring sleep apnea. The Technology and IP are protected via international patents - sleep apnea detection and sleep phases analysis through sound wave analysis, developed in the Biomedical Department of Ben Gurion University in Beer Sheva, Israel.Based on this technology, one of the leading products SleepX offers is a unique night bracelet for the treatment of snoring using artificial Intelligence", said Bary Molchadsky, CEO of SleepX.
(0)
(0)